Coparvax for malignant effusion?
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D001428:Bacterial Vaccines / Q000627:therapeutic use*; D003352:Corynebacterium; D005260:Female; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D010996:Pleural Effusion / Q000628:therapy*; D011425:Propionibacterium acnes / Q000276:immunology*
D000276:Adjuvants, Immunologic; D001428:Bacterial Vaccines; C039725:Corynebacterium parvum vaccine